Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer

Published:2019-09-13 Issue: Volume:6 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Zeindler Jasmin,Soysal Savas Deniz,Piscuoglio Salvatore,Ng Charlotte K. Y.,Mechera Robert,Isaak Andrej,Weber Walter Paul,Muenst Simone,Kurzeder Christian

Publisher

Frontiers Media SA

Subject

General Medicine

Reference28 articles.

1. Breast cancer subtypes and the risk of local and regional relapse;Voduc;J Clin Oncol,2010

2. Subtype-dependent relationship between young age at diagnosis and breast cancer survival;Partridge;J Clin Oncol,2016

3. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel;Millar;J Clin Oncol,2009

4. Measures of outcome in metastatic breast cancer: insights from a real-world scenario;Bonotto;Oncologist,2014

5. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies;Lehmann;J Clin Invest,2011

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nectin-4-directed antibody-drug conjugates (ADCs): Spotlight on preclinical and clinical evidence;Life Sciences;2024-09

2. Emerging Targets and Therapeutics in Immuno-Oncology: Insights from Landscape Analysis;Journal of Medicinal Chemistry;2024-05-24

3. Genomic and transcriptomic significance of multiple primary lung cancers detected by next-generation sequencing in clinical settings;Carcinogenesis;2024-05-02

4. Therapeutic prospects of nectin-4 in cancer: applications and value;Frontiers in Oncology;2024-03-28

5. [²²⁵Ac]Ac/[⁸⁹Zr]Zr-labeled N4MU01 radioimmunoconjugates as theranostics against nectin-4 positive triple negative breast cancer;2024-03-08